Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eklund Foundation scholarship recipient lectured at TePe

TePe has had the honour of welcoming Dr Yohei Jinno, who was granted the 2018 Eklund Foundation Scholarship for the promotion of odontological research. Dr Jinno was recently awarded a scholarship of approx. EUR 15,000 for his project on custom-made bone regeneration at the Faculty of Odontology at Malmö University. Together with his supervisor Dr Becktor, Dr Jinno came to introduce his research to a group of eager listeners at TePe Oral Hygiene Products, and kindly answered our questions about his life and work. Dr Jinno, what do you hope to achieve with your research? My research

Mr Green launches Swish in Sweden

Mr Green expand their selection of payment options by introducing Swish for the Swedish market. Swish is currently the favoured payment service in Sweden with 6.7million active users and 180,000 connected businesses.The Swedish mobile payment system Swish works through a smartphone application, through which the user's phone number is connected to their bank account.  Mr Green’s mission is to offer a superior gaming experience in a responsible environment. By offering Swish connected to BankID, Mr Green looks to strengthen the user experience. “The online consumer behaviour in Sweden

SSAB introduces new Strenx® 1100 Plus structural steel for lifting and advanced structures

Fleet and equipment owners continue to face the pressure of doing more with less. To this end, SSAB has created a new addition to the 1100 MPa range of Strenx® performance steels. Strenx® 1100 Plus  is a new hot-rolled, high-strength strip steel that possesses unique weld properties and delivers outstanding welding and bending performance. And thanks to its improved weld seam strength, it contributes to lighter, stronger and

How does color affect us? In conversation with two experts with a keen eye for the right hue.

In popular culture, colors are portrayed to have the power to energize, anger and charm. They have even been used as indicators of personality traits. But what is their real impact on us? We meet Harald Arnkil, lecturer in color studies at Aalto University since 1990 and Irina Hanhisalo, Tikkurila’s color marketing manager, at the heart of Tikkurila, to discuss the importance of colors – and why sometimes a color can feel as real as a punch. Behind the colors In this blog series, we venture into the world of color and meet specialists across the field to discuss sustainable

Taking a load off the environment with SSAB EcoUpgraded

At SSAB, we are convinced that good environmental stewardship also drives good business. We are firmly committed to reducing our own carbon footprint and that of our customers. We take action in many different ways – as a signatory to the UN Global Compact, through our membership in environmental research projects and organizations, and by improving our own manufacturing processes, procedures and policies. But perhaps our most important effort stems from collaborating with customers. With our SSAB EcoUpgraded program, customers can upgrade to high-strength steel and reduce the weight of

Invitation to presentation of Humana’s fourth quarter report 2018

Humana’s interim report for the fourth quarter 2018 will be published at 08:00 CET on February 14, 2019. A web-cast telephone conference will be held at 09:00 CET the same day, where CEO and President Rasmus Nerman and CFO Ulf Bonnevier will present the report.A possibility will be given to ask questions via the webcast and follow the presentation material live. The webcast, which afterwards also will be available on demand, will be accessible at Humana’s financial website, http://corporate.humana.se. The presentation and webcast is also available on www.financialhearings.com. To

Invitation to presentation of Bravida’s report for the fourth quarter and Year-end Report for 2018 on the 15th of February 2019

Bravida’s report for the fourth quarter 2018 will be published 07:30 CET on the 15th of February 2019.The report will be presented at 09:30 CET by CEO and Group President Mattias Johansson and CFO Nils-Johan Andersson. The presentation will be held in English and can be followed on the web or over the phone. There will be room for questions. Link to the webcast:https://tv.streamfabriken.com/bravida-q4-2018 Telephone numbers for telephone conference:SE: +46 8 5664 27 06UK: +44 33 3300 9031US: +1 646 722 49 02 The report and the presentation will be available on www.bravida.

Broad-based decline in confidence in January

The Economic Tendency Indicator fell for a fourth month from 105.6 in December to 101.9 in January following weaker signals from all sectors otherthan construction.The confidence indicator for the manufacturing industry fell 4 points in January and has dropped no fewer than 10 points in five months. It is still above 110, however, a level that points to a much stronger situation than normal. The decline is relatively broad-based, with most of the subsector indicators having fallen. The confidence indicator for the building and civil engineering industry increased marginally for a

New Hardox 500 Tuf wear steel helps heavy-duty bucket manufacturer Winkelbauer get tough on wear

Winkelbauer GmbH in Austria is a leading supplier of heavy-duty buckets and other construction equipment for the European market. The company is an early adopter of SSAB’s new wear-resistant steel grade Hardox 500 Tuf. Upgrading to this material allows Winkelbauer’s customers to load more and extend the service life of their equipment.Hardox 500 Tuf is an abrasion-resistant (AR) steel that makes the perfect fit for the high-performance buckets manufactured by Winkelbauer. Hardox 500 Tuf is the first 500 Brinell (HB) wear plate with properties on a par with structural steel. It delivers high

Invitation to presentation of Addnode Group’s interim report for Q4 2018

Addnode Group’s interim report for Q4 2018 will be published on Wednesday, 6 February 2019 at 8.30 a.m. CET. On the same day at 09.30 a.m. CET, Addnode Group’s President and CEO, Johan Andersson will present the report at a press- and analyst conference at Addnode Groups headquarter in Stockholm. After the presentation, there will be an opportunity to ask Johan Andersson and Helena Nathhorst, CFO, questions.Location for the presentation: Hudiksvallsgatan 4B, Stockholm, Sweden. Please confirm your attendance to: receptionen@addnodegroup.com no later than February 5, 2019 at 4 p.m

Nanogate Secures TactoTek® IMSE™ Manufacturing Rights, Targets Several Markets

Preferred manufacturing partner will be IMSE Ready for mass production in Austria in 2019OULU, FINLAND/GÖTTELBORN,GERMANY (30 January 2019) – Today TactoTek®, the leading developer of injection molded structural electronics (IMSE™) solutions, announced that Nanogate, a leading global specialist for design-oriented high-tech surfaces and components, will promote and manufacture IMSE solutions as a TactoTek IMSE licensee. Technology transfer is underway, and Nanogate expects to be IMSE Ready for mass production by the end of 2019. Nanogate currently has 10 factories:  six in Germany, and one

UPM Raflatac introduces Syntyre Plus for excellent lay-flat performance in tire-tread labeling

(UPM Raflatac, Helsinki, 30 January 2019 at 10:00 EET) - UPM Raflatac is broadening its already extensive range of dedicated tire-labeling solutions with the introduction of Syntyre Plus, a polypropylene (PP) film that has been specially designed to withstand the tough challenges of tire labeling applications. A special barrier layer on the backside of the film combines with the RHT tire adhesive to ensure that labels stay looking good with no edge lift or staining, with safety-critical information and key branding elements remaining in place and readable until the label is no longer

AVIDLY'S NEW STRATEGY 2019–2024, MID-TERM FINANCIAL TARGETS AND DIVIDEND POLICY

Avidly Plc, Company Announcement 30 Jan 2019 at 9:40 EET Targeting a revenue of EUR 100 million in 2024 Avidly Plc's Board of Directors has, on 30 January 2019, approved the new strategy and mid-term financial targets for Avidly and confirmed a new dividend policy. In 2019–2024, Avidly is targeting the annual organic revenue growth to exceed 25% and overall revenue growth to exceed 40%. Avidly targets its revenues to exceed EUR 100 million in 2024. The Board of Directors also updated Avidly’s dividend policy to better reflect the strong growth mode of the strategy period. Strong

Patients treated with ProTrans in phase II of the clinical trial

NextCell Pharma AB ("NextCell") hereby announces that they today have reached a significant milestone as they have now initiated the second part of the ProTrans-1 clinical trial. In addition to safety, clinical efficacy is evaluated, e.g. whether the patient's own insulin production improves 12 months after treatment with ProTrans compared to placebo. The phase-II part is randomized, double-blind, placebo-controlled which means that neither the patient nor the doctor knows what treatment the patient is receiving. So far, two patients have undergone treatment. In total, 15 patients will be

Interim report 2018-01-01 - 2018-12-31

Interim report – SummarySince OmniCar Holding AB was formed in May 2017, no comparative figures for the first four months of 2017 are available for the parent company. The 2017 numbers presented include previous marketing services revenue that no longer forms part of OMNICAR’s services. OMNICAR is now a software company based on recurrent monthly licence revenue. Year-to-date (2018-01-01 – 2018-12-31)  · YTD revenue totalled SEK 13 979 thousand  · Net loss for YTD amounted to SEK –27 019  · YTD earnings per share* is SEK – 1.86  Q4 2018 (2018-10-01 - 2018-12-31)  ·

Net Gaming expands its management team with a new Head of M&A

Net Gaming has appointed Christian Käfling as its new Head of M&A. Christian comes most recently from PwC, where he worked for more than ten years as an advisor in the Deals department, with a focus on strategy and commercial due diligence, mainly in iGaming and the TMT sector. Before that, he held various positions in product and business development at Telia Sonera for ten years.“We are delighted to have been able to recruit Christian Käfling as the new Head of M&A. Christian has extensive knowledge in the iGaming industry, having carried out consultancy work for various companies in the

Sivers IMA sign agreement for use of unlicensed 5G in ultra sonic examination application

Today,Sivers IMA Holding AB (Nasdaq First North: SIVE, the Company) announces it has, together with their Japanese reseller, NetWell, and baseband partner CLOP Technologies signed a Memorandum of Understanding with a Japanese provider of leading technology using radio technology in the medical equipment field.This company has a focus on utilizing wireless data transfer technology in their new products. Sivers IMA will participate in the development of an unlicensed 5G (WiGig) solution to be used for wireless transfer of high definition ultra sonic data. The estimates order value relating to

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release January 30, 2019, at 9:30 a.m.  Nokian Tyres has received an announcement from BlackRock, Inc. on January 29, 2019, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the total number of Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below level of 5% of the share capital in Nokian Tyres plc, as result of share transactions concluded on January 28, 2019. Total positions of BlackRock, Inc. and its funds subject to the notification:  +----------------+----------+------------

Ravicti® now available for all ages in Europe following approval of the expanded paediatric indication

Swedish Orphan Biovitrum AB (publ)  (Sobi™) announces that Ravicti®, a therapy option for the treatment of patients with urea cycle disorders (UCDs), has received approval from the European Commission on 18 December 2018 for the paediatric indication (birth to two months of age) following a positive CHMP opinion from the European Medicines Agency (EMA). The previous indication for Ravicti (glycerol phenylbutyrate) was restricted to children aged more than two months.  “This new expanded indication allows all patients access to treatment, which is particularly

Scandic appoints Søren Faerber as new Head of Denmark and member of the Executive Committee

Søren Faerber has been appointed as Managing Director of Scandic Denmark. He will start immediately and will also be a member of Scandic’s Executive Committee. Søren is 48 years old and has many years of experience from management positions in Scandic’s Danish operations.Søren has been a part of Scandic’s management team in Denmark since 2006 and has worked as district manager for the Copenhagen region for the last four years.   - Søren has extensive knowledge of the Danish market and has successfully managed our operations in the Copenhagen region where we currently have 12 hotels in

Beijer Ref AB Q4-2018

Increased profit and dividendNet sales for the fourth quarter of 2018 increased by 37% compared with the corresponding period in the previous year and totalled SEK 3,293 million (2,401). The operating profit for the fourth quarter of 2018 totalled SEK 229 million (179), an increase of 28% compared with the same period last year. The profit for the period totalled SEK 164 million (146). Profit per share totalled SEK 1.28 (1.13). During the fourth quarter, Beijer Ref AB issued a commercial paper scheme totalling SEK 700 million as part of the company’s existing financing.

Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme

Press release 30 January 2019 First patients included in large placebo-controlled multicentre study on ColdZyme Enzymatica has initiated a prospective double-blind, placebo-controlled multicentre study to evaluate the effects of ColdZyme® Mouth Spray on the common cold. The study will include 600 patients and is conducted at 10 study centres in Germany. The first patients have now been enrolled in the study, which is expected to be completed during the second half of 2019. The goal of the study is to evaluate clinical effects of ColdZyme on the common cold. The primary objective

DNB accepts bid from Nasdaq

At the beginning of January, the Board of Directors of Oslo Børs VPS Holding ASA invited relevant interested parties to make a bid for the shares of the company. Nasdaq has today announced that they will submit an offer that is higher than the current bid from Euronext.   After due consideration of the bids, the Board has given the shareholders a comprehensive justification for why they believe the Nasdaq bid to be the best solution, from both a financial and an industrial perspective. The Board of Directors recommends the shareholders to accept the bid from Nasdaq.   DNB agrees with

There are no items matching the current filter
There are no more items matching the current filter
Back to top